French recommendations for the management of Behçet's disease.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
24 02 2021
Historique:
entrez: 24 2 2021
pubmed: 25 2 2021
medline: 7 10 2021
Statut: epublish

Résumé

Behçet's disease (BD) is a systemic variable vessel vasculitis that involves the skin, mucosa, joints, eyes, arteries, veins, nervous system and gastrointestinal system, presenting with remissions and exacerbations. It is a multifactorial disease, and several triggering factors including oral cavity infections and viruses may induce inflammatory attacks in genetically susceptible individuals. BD vasculitis involves different vessel types and sizes of the vascular tree with mixed-cellular perivascular infiltrates and is often complicated by recurrent thrombosis, particularly in the venous compartment. Several new therapeutic modalities with different mechanisms of action have been studied in patients with BD. A substantial amount of new data have been published on the management of BD, especially with biologics, over the last years. These important therapeutic advances in BD have led us to propose French recommendations for the management of Behçet's disease [Protocole National de Diagnostic et de Soins de la maladie de Behçet (PNDS)]. These recommendations are divided into two parts: (1) the diagnostic process and initial assessment; (2) the therapeutic management. Thirty key points summarize the essence of the recommendations. We highlighted the main differential diagnosis of BD according to the type of clinical involvement; the role of genetics is also discussed, and we indicate the clinical presentations that must lead to the search for a genetic cause.

Identifiants

pubmed: 33622338
doi: 10.1186/s13023-020-01620-4
pii: 10.1186/s13023-020-01620-4
pmc: PMC7903591
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

352

Investigateurs

Achille Aouba (A)
Marc Bayen (M)
Patrice Cacoub (P)
Raphael Darbon (R)
Alban Deroux (A)
Brigitte Granel (B)
Mohamed Hamidou (M)
Laurent Kodjikian (L)
Marc Lambert (M)
Dan Lipsker (D)
Céline Marsaud (C)
François Maurier (F)
Isabelle Melki (I)
Tristan Mirault (T)
Antoine Parrot (A)
Aurelie Plessier (A)
Grégory Pugnet (G)
Karine Retornaz (K)
Sophie Riviere (S)
Karim Sacre (K)
Philippe Seksik (P)
Damien Sene (D)
Pascal Seve (P)
Stephanie Tellier (S)
Benjamin Terrier (B)

Références

Surv Ophthalmol. 2005 Jan-Feb;50(1):27-47
pubmed: 15621076
Clin Rheumatol. 2016 Feb;35(2):501-5
pubmed: 25665824
Br J Ophthalmol. 2007 Mar;91(3):335-9
pubmed: 17050581
Curr Opin Ophthalmol. 2011 Nov;22(6):508-16
pubmed: 21897239
J Neurol. 2009 Apr;256(4):513-29
pubmed: 19444529
Semin Arthritis Rheum. 2016 Jun;45(6):733-7
pubmed: 26743073
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350
pubmed: 15967189
Semin Ophthalmol. 2005 Jul-Sep;20(3):199-206
pubmed: 16282155
Neuroradiology. 2003 Dec;45(12):851-9
pubmed: 14557904
Lancet. 1990 May 5;335(8697):1078-80
pubmed: 1970380
Ann Rheum Dis. 2018 Jun;77(6):808-818
pubmed: 29625968
Autoimmun Rev. 2013 May;12(7):774-83
pubmed: 23470459
Am J Ophthalmol. 2011 Dec;152(6):1059-66
pubmed: 21872204
Brain. 1999 Nov;122 ( Pt 11):2171-82
pubmed: 10545401
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1692-5
pubmed: 16673135
N Engl J Med. 1990 Feb 1;322(5):281-5
pubmed: 2404204
Intractable Rare Dis Res. 2015 May;4(2):70-5
pubmed: 25984424
Arch Ophthalmol. 2011 Mar;129(3):288-94
pubmed: 21402983
Br J Urol. 1991 Jun;67(6):638-9
pubmed: 2070210
Rheumatology (Oxford). 2019 Jul 1;58(7):1227-1238
pubmed: 30715505
Clin Rheumatol. 2017 Jan;36(1):191-197
pubmed: 27981463
J Pediatr. 1998 Apr;132(4):721-5
pubmed: 9580778
Brain. 1999 Nov;122 ( Pt 11):2183-94
pubmed: 10545402
Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2878-84
pubmed: 1526738
Middle East Afr J Ophthalmol. 2009 Oct;16(4):219-24
pubmed: 20404988
Br J Ophthalmol. 1986 Aug;70(8):589-92
pubmed: 3741823
Medicine (Baltimore). 2003 Jan;82(1):60-76
pubmed: 12544711
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):119-123
pubmed: 28406761
Rev Med Interne. 2014 Feb;35(2):112-20
pubmed: 24290030
Int J Pediatr Nephrol. 1983 Mar;4(1):35-7
pubmed: 6853039
Pol Arch Intern Med. 2018 Mar 29;128(3):148-149
pubmed: 29600965
Neurology. 2011 Nov 22;77(21):1900-5
pubmed: 22076549
Arthritis Rheum. 2009 Apr 15;61(4):518-26
pubmed: 19333987
Semin Arthritis Rheum. 2015 Dec;45(3):369-73
pubmed: 26190564
Neuropediatrics. 2010 Oct;41(5):228-34
pubmed: 21210339
Am J Ophthalmol. 2017 Jun;178:176-185
pubmed: 28366648
J Neurol. 2014 Sep;261(9):1662-76
pubmed: 24366648
Arthritis Rheumatol. 2016 Jun;68(6):1522-30
pubmed: 27015607
Ann Rheum Dis. 2008 Dec;67(12):1656-62
pubmed: 18245110
Arthritis Care Res (Hoboken). 2010 Dec;62(12):1733-8
pubmed: 20665749
Medicine (Baltimore). 2012 Jan;91(1):35-48
pubmed: 22210555
Rheumatology (Oxford). 2011 Jan;50(1):184-8
pubmed: 21036877
J Autoimmun. 2015 Aug;62:67-74
pubmed: 26162757
Autoimmun Rev. 2016 Apr;15(4):375-8
pubmed: 26777307
Arthritis Rheum. 2012 Aug;64(8):2753-60
pubmed: 22354392
Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S39-44
pubmed: 20868569
Am J Ophthalmol. 2004 Sep;138(3):373-80
pubmed: 15364218
Clin Rheumatol. 2016 May;35(5):1281-6
pubmed: 26156661
Ocul Immunol Inflamm. 2012 Oct;20(5):324-35
pubmed: 23030353
Int Ophthalmol Clin. 2012 Fall;52(4):183-90
pubmed: 22954940
Medicine (Baltimore). 2012 Jan;91(1):18-24
pubmed: 22198498
Ocul Immunol Inflamm. 2012 Dec;20(6):423-8
pubmed: 23163330
Joint Bone Spine. 2019 Oct;86(5):554-561
pubmed: 30471422
Ann Rheum Dis. 2016 Jun;75(6):958-64
pubmed: 26698843
Rheumatology (Oxford). 2012 Jul;51(7):1216-25
pubmed: 22337940
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62
pubmed: 25005224
Rev Neurol (Paris). 2006 Nov;162(11):1084-90
pubmed: 17086145
Arthritis Rheum. 2007 Feb 15;57(1):171-8
pubmed: 17266063
Ophthalmology. 2008 Feb;115(2):312-318.e4
pubmed: 17692378
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47
pubmed: 23441863
Medicine (Baltimore). 2015 Feb;94(6):e494
pubmed: 25674739
Ocul Immunol Inflamm. 2011 Apr;19(2):103-7
pubmed: 21428747

Auteurs

Isabelle Kone-Paut (I)

Pediatric Rheumatology and CEREMAIA, Bicêtre Hospital APHP, University of Paris Sud Saclay, Le Kremlin-Bicêtre, France. isabelle.kone-paut@aphp.fr.

Stéphane Barete (S)

Unit of Dermatology, DMU3ID, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-UMRS 959, Sorbonne Universités, Paris, France.

Bahram Bodaghi (B)

Department of Ophthalmology, CRMR OPHTARA, IHU FOReSIGHT, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris, France.

Kumaran Deiva (K)

Department of Pediatric Neurology, National Referral Center for Rare Inflammatory Brain and Spinal Diseases, Assistance Publique-Hopitaux de Paris, University Hospitals of Paris-Saclay, Bicêtre Hospital, Paris, France.
Inserm UMR1184, Immunology of Viral Infections and Autoimmune Diseases, University Paris Saclay, Le Kremlin-Bicêtre, France.

Anne-Claire Desbois (AC)

UPMC Université Paris 06, Inserm UMR S 959, Immunology Immunopathology Immunotherapy (I3), Sorbonne Universités, 75005, Paris, France.
Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, AP-HP, 75651, Paris, France.
AP-HP groupe hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, centre national de référence maladies autoinflammatoires et amylose inflammatoire, centre national de références maladies autoimmunes systémiques rares, 75013, Paris, France.

Caroline Galeotti (C)

Pediatric Rheumatology and CEREMAIA, Bicêtre Hospital APHP, University of Paris Sud Saclay, Le Kremlin-Bicêtre, France.

Julien Gaudric (J)

Department of Vascular Surgery, Pitié-Salpétrière Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.

Gilles Kaplanski (G)

Internal Medicine and Clinical Immunology Department, Hôpital de la Conception, Aix-Marseille Université, Marseille, France.

Alfred Mahr (A)

Clinic for Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.

Nicolas Noel (N)

Assistance Publique-Hôpitaux de Paris, Service de Médecine Interne et Immunologie Clinique, CHU Bicêtre, Le Kremlin Bicêtre, France.
INSERM, UMR 1184, Immunologie des Maladies Virales et Autoimmunes, Université Paris Saclay, Le Kremlin Bicêtre, France.
CEA, DSV/iMETI, Division of Immuno-Virology, IDMIT, Fontenay aux Roses, France.

Maryam Piram (M)

Pediatric Rheumatology and CEREMAIA, Bicêtre Hospital APHP, University of Paris Sud Saclay, Le Kremlin-Bicêtre, France.
Pediatric Dermatology, CHU Sainte Justine Research Centre, CHU Sainte Justine, University of Montreal, Montreal, Canada.

Tu-Anh Tran (TA)

Department of Pediatrics, Nîmes University Hospital, INSERM U1183, Montpellier-Nîmes University, Nîmes, France.

Bertrand Wechsler (B)

UPMC Université Paris 06, Inserm UMR S 959, Immunology Immunopathology Immunotherapy (I3), Sorbonne Universités, 75005, Paris, France.
Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, AP-HP, 75651, Paris, France.
AP-HP groupe hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, centre national de référence maladies autoinflammatoires et amylose inflammatoire, centre national de références maladies autoimmunes systémiques rares, 75013, Paris, France.

David Saadoun (D)

UPMC Université Paris 06, Inserm UMR S 959, Immunology Immunopathology Immunotherapy (I3), Sorbonne Universités, 75005, Paris, France. david.saadoun@aphp.fr.
Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, AP-HP, 75651, Paris, France. david.saadoun@aphp.fr.
AP-HP groupe hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, centre national de référence maladies autoinflammatoires et amylose inflammatoire, centre national de références maladies autoimmunes systémiques rares, 75013, Paris, France. david.saadoun@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH